MedTrace Logo

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

NCT01742689 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2012-12-05

No results posted yet for this study

Summary

In this study we will compare pain intensity and side effects at different time points after the intranasal administration of desmopressin or placebo in patients with acute renal colic pain.

Conditions

Interventions

DRUG

Desmopressin intranasal spray

10 microgram per puff, 40 microgram is Descript

DRUG

Placebo intranasal spray

Saline spray identical to desmopressin, administered as 4 sprays

DRUG

Indomethacin suppository

Indomethacin suppository 100 milligram single dose

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mohammad Jalili, MD · Tehran University of Medical Sciences

  • Mohammadreza Hedayatshodeh, MD · Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01742689 on ClinicalTrials.gov